Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2FWW

human beta-tryptase II complexed with 4-piperidinebutyrate to make acylenzyme

Summary for 2FWW
Entry DOI10.2210/pdb2fww/pdb
Related2FX4 2FX6
DescriptorTryptase beta-2, 4-PIPERIDINEBUTYRATE (3 entities in total)
Functional Keywordsserine protease, proteinase, 29382, hydrolase
Biological sourceHomo sapiens (human)
Cellular locationSecreted: P20231
Total number of polymer chains4
Total formula weight110586.65
Authors
Katz, B.A. (deposition date: 2006-02-03, release date: 2006-02-14, Last modification date: 2017-10-18)
Primary citationMcGrath, M.E.,Sprengeler, P.A.,Hirschbein, B.,Somoza, J.R.,Lehoux, I.,Janc, J.W.,Gjerstad, E.,Graupe, M.,Estiarte, A.,Venkataramani, C.,Liu, Y.,Yee, R.,Ho, J.D.,Green, M.J.,Lee, C.-S.,Liu, L.,Tai, V.,Spencer, J.,Sperandio, D.,Katz, B.A.
Structure-guided design of Peptide-based tryptase inhibitors.
Biochemistry, 45:5964-5973, 2006
Cited by
PubMed Abstract: Improved peptide-based inhibitors of human beta tryptase were discovered using information gleaned from tripeptide library screening and structure-guided design methods, including fragment screening. Our efforts sought to improve this class of inhibitors by replacing the traditional Lys or Arg P1 element. The optimized compounds display low nanomolar potency against the mast cell target and several hundred-fold selectivity with respect to serine protease off targets. Thus, replacement of Lys/Arg at P1 in a peptide-like scaffold does not need to be accompanied by a loss in target affinity.
PubMed: 16681368
DOI: 10.1021/bi060173m
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.25 Å)
Structure validation

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon